Key facts
- This page summarizes Power Benjamin Carson Sr.'s Form 3 filing for GALECTIN THERAPEUTICS INC (GALT).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Feb 2024, 08:50.
Power Benjamin Carson Sr. - 07 Dec 2023 Form 3 Insider Report for GALECTIN THERAPEUTICS INC (GALT)
- Reporting relationship
- Director
- Issuer ticker
- GALT
- Reported as of
- 07 Dec 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Feb 2024, 08:50:09 UTC
- Prior SEC filing
- 23 May 2023
- Next SEC filing
- 07 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- Jack W. Callicutt, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Power Benjamin Carson Sr. filed Form 3 for GALECTIN THERAPEUTICS INC (GALT) on 16 Feb 2024.
Change
- Previous filing in this sequence was filed on 23 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GALT
holding
Derivative
Common Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $2.23
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Common Stock Options were granted to the Reporting Person by the Issuer in connection with services to be provided by the Reporting Person as a consultant prior to the Reporting Person's election to the Board of Directors. The options vested and became exercisable upon several vesting dates beginning on July 16, 2021 and ending April 16, 2023.